# AETON THERAPEUTICS, INC.: Human CGAS inhibitors to treat neurodegeneration in Alzheimer's disease

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | AETON THERAPEUTICS, INC. |
| Location | BURLINGAME, CA |
| Project | Human CGAS inhibitors to treat neurodegeneration in Alzheimer's disease |
| Project number | 1R44AG099654-01 |
| Mechanism | R44 |
| Institute | National Institute on Aging |
| Award | $932,681 |
| Awarded | 2026-09-17 |
| Project period | 2026-09-17 to 2028-05-31 |
| UEI | MC2DMP4NVUC7 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11323824). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.